ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ELTP Elite Pharmaceuticals Inc (QB)

0.1705
0.0015 (0.89%)
May 24 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 818,984
Bid Price 0.17
Ask Price 0.175
News -
Day High 0.175

Low
0.0301

52 Week Range

High
0.2119

Day Low 0.165
Company Name Stock Ticker Symbol Market Type
Elite Pharmaceuticals Inc (QB) ELTP OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0015 0.89% 0.1705 16:15:26
Open Price Low Price High Price Close Price Prev Close
0.165 0.165 0.175 0.1705 0.169
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
113 818,984 $ 0.171557 $ 140,502 - 0.0301 - 0.2119
Last Trade Time Type Quantity Stock Price Currency
15:57:52 2,000 $ 0.1705 USD

Elite Pharmaceuticals Inc (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
173.02M 1.01B 705.48M 34.16M 3.56M 0.00 48.57
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Elite Pharmaceuticals (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ELTP Message Board. Create One! See More Posts on ELTP Message Board See More Message Board Posts

Historical ELTP Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.1390.1750.13510.1568922694,1550.031522.66%
1 Month0.1290.1750.12310.1423083576,6030.041532.17%
3 Months0.16490.1750.12130.1431028621,4730.00563.40%
6 Months0.15850.21190.12130.16100521,102,4310.0127.57%
1 Year0.03220.21190.03010.12601341,124,3820.1383429.50%
3 Years0.054550.21190.0230.0837047742,1660.11595212.56%
5 Years0.07830.21190.0230.0785137836,0820.0922117.75%

Elite Pharmaceuticals (QB) Description

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to Lannett Company, Prasco, LLC, Epic Pharma, LLC, and TAGI Pharma. Elite operates a cGMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. For more information, visit www.elitepharma.com.